Glipizide 10 MG Oral Tablet — RxCUI 310488
RxNorm drug concept · Semantic clinical drug
RxCUI 310488
Semantic clinical drug · SCD
● Current RxNorm concept 61 FDA products
198 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI310488
Official nameGlipizide 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped61
Package NDCs mapped198
Reported Medicaid activity (SDUD)892,158 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Glipizide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Glipizide helps lower your blood sugar by prompting your pancreas to release more insulin — especially after meals. It's used in type 2 diabetes alongside diet and exercise, not as...
- What exactly is glipizide supposed to do for my diabetes?
- The regular tablet works relatively quickly and is usually taken about 30 minutes before a meal. The extended-release tablet (including the brand Glucotrol XL) releases the medicin...
- What's the difference between the regular tablet and the extended-release tablet?
🕸️ Concept Web — How Glipizide 10 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Glipizide 10 MG Oral Tablet
RxCUI 310488 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Glipizide
4821IN
-
Glipizide
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Glipizide Oral Tablet
372320SCDF -
Glipizide Oral Product
1165207SCDG -
Glipizide Pill
1165208SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Glipizide Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Glipizide 10 MG
317379SCDC
-
Glipizide 10 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Glipizide 10 MG
SCDC · 317379 -
Glipizide Oral Tablet
SCDF · 372320 -
Glipizide Oral Product
SCDG · 1165207 -
Glipizide Pill
SCDG · 1165208
📦 FDA Products & Package NDCs
61 products · 198 package NDCs
198 package NDCs map to RxCUI 310488 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00591-0460-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-0460-01) | Glipizide | Actavis Pharma, Inc. | 1995-02-27 |
| 00591-0460-05 | 500 TABLET in 1 BOTTLE, PLASTIC (0591-0460-05) | Glipizide | Actavis Pharma, Inc. | 1995-02-27 |
| 00591-0460-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (0591-0460-10) | Glipizide | Actavis Pharma, Inc. | 1995-02-27 |
| 00591-0461-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-0461-01) | Glipizide | Actavis Pharma, Inc. | 1995-02-27 |
| 00591-0461-05 | 500 TABLET in 1 BOTTLE, PLASTIC (0591-0461-05) | Glipizide | Actavis Pharma, Inc. | 1995-02-27 |
| 00591-0461-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (0591-0461-10) | Glipizide | Actavis Pharma, Inc. | 1995-02-27 |
| 00615-8407-05 | 15 TABLET in 1 BLISTER PACK (0615-8407-05) | Glipizide | NCS HealthCare of KY, LLC dba Vangard Labs | 2021-10-07 |
| 00615-8407-39 | 30 TABLET in 1 BLISTER PACK (0615-8407-39) | Glipizide | NCS HealthCare of KY, LLC dba Vangard Labs | 2021-10-07 |
| 00615-8408-39 | 30 TABLET in 1 BLISTER PACK (0615-8408-39) | Glipizide | NCS HealthCare of KY, LLC dba Vangard Labs | 2021-10-06 |
| 43063-0861-14 | 14 TABLET in 1 BOTTLE, PLASTIC (43063-861-14) | Glipizide | PD-Rx Pharmaceuticals, Inc. | 2018-06-12 |
| 43063-0861-30 | 30 TABLET in 1 BOTTLE, PLASTIC (43063-861-30) | Glipizide | PD-Rx Pharmaceuticals, Inc. | 2018-06-12 |
| 43063-0861-60 | 60 TABLET in 1 BOTTLE, PLASTIC (43063-861-60) | Glipizide | PD-Rx Pharmaceuticals, Inc. | 2018-06-12 |
| 43063-0861-90 | 90 TABLET in 1 BOTTLE, PLASTIC (43063-861-90) | Glipizide | PD-Rx Pharmaceuticals, Inc. | 2018-06-12 |
| 43063-0861-93 | 180 TABLET in 1 BOTTLE, PLASTIC (43063-861-93) | Glipizide | PD-Rx Pharmaceuticals, Inc. | 2018-06-12 |
| 43063-0861-98 | 120 TABLET in 1 BOTTLE, PLASTIC (43063-861-98) | Glipizide | PD-Rx Pharmaceuticals, Inc. | 2018-06-12 |
| 50090-0505-00 | 30 TABLET in 1 BOTTLE (50090-0505-0) | Glipizide | A-S Medication Solutions | 2016-06-29 |
| 50090-0505-01 | 60 TABLET in 1 BOTTLE (50090-0505-1) | Glipizide | A-S Medication Solutions | 2014-11-28 |
| 50090-0505-02 | 100 TABLET in 1 BOTTLE (50090-0505-2) | Glipizide | A-S Medication Solutions | 2014-11-28 |
| 50090-0505-05 | 90 TABLET in 1 BOTTLE (50090-0505-5) | Glipizide | A-S Medication Solutions | 2014-11-28 |
| 50090-0505-06 | 180 TABLET in 1 BOTTLE (50090-0505-6) | Glipizide | A-S Medication Solutions | 2016-06-29 |
| 50090-6996-00 | 90 TABLET in 1 BOTTLE (50090-6996-0) | Glipizide | A-S Medication Solutions | 2023-12-27 |
| 50090-7197-00 | 90 TABLET in 1 BOTTLE (50090-7197-0) | Glipizide | A-S Medication Solutions | 2024-07-24 |
| 50090-7404-00 | 30 TABLET in 1 BOTTLE (50090-7404-0) | Glipizide | A-S Medication Solutions | 2024-10-24 |
| 50090-7404-01 | 60 TABLET in 1 BOTTLE (50090-7404-1) | Glipizide | A-S Medication Solutions | 2024-10-24 |
| 50090-7404-02 | 100 TABLET in 1 BOTTLE (50090-7404-2) | Glipizide | A-S Medication Solutions | 2024-10-24 |
| 50090-7404-05 | 90 TABLET in 1 BOTTLE (50090-7404-5) | Glipizide | A-S Medication Solutions | 2024-10-24 |
| 50090-7404-06 | 180 TABLET in 1 BOTTLE (50090-7404-6) | Glipizide | A-S Medication Solutions | 2024-10-24 |
| 50090-7405-00 | 90 TABLET in 1 BOTTLE (50090-7405-0) | Glipizide | A-S Medication Solutions | 2024-10-24 |
| 50090-7734-00 | 30 TABLET in 1 BOTTLE (50090-7734-0) | Glipizide | A-S Medication Solutions | 2025-10-28 |
| 50090-7734-01 | 60 TABLET in 1 BOTTLE (50090-7734-1) | Glipizide | A-S Medication Solutions | 2025-10-28 |
| 50090-7734-02 | 100 TABLET in 1 BOTTLE (50090-7734-2) | Glipizide | A-S Medication Solutions | 2025-10-28 |
| 50090-7734-05 | 90 TABLET in 1 BOTTLE (50090-7734-5) | Glipizide | A-S Medication Solutions | 2025-10-28 |
| 50090-7734-06 | 180 TABLET in 1 BOTTLE (50090-7734-6) | Glipizide | A-S Medication Solutions | 2025-10-28 |
| 50090-7735-00 | 90 TABLET in 1 BOTTLE (50090-7735-0) | Glipizide | A-S Medication Solutions | 2025-10-28 |
| 50268-0361-15 | 50 BLISTER PACK in 1 BOX (50268-361-15) / 1 TABLET in 1 BLI... | Glipizide | AvPAK | 2020-07-10 |
| 50268-0362-15 | 50 BLISTER PACK in 1 BOX (50268-362-15) / 1 TABLET in 1 BLI... | Glipizide | AvPAK | 2020-07-10 |
| 51407-0620-10 | 1000 TABLET in 1 BOTTLE (51407-620-10) | Glipizide | Golden State Medical Supply, Inc. | 2022-01-12 |
| 51407-0621-10 | 1000 TABLET in 1 BOTTLE (51407-621-10) | Glipizide | Golden State Medical Supply, Inc. | 2022-01-12 |
| 51655-0106-25 | 60 TABLET in 1 BOTTLE, DISPENSING (51655-106-25) | Glipizide | Northwind Health Company, LLC | 2014-12-30 |
| 51655-0106-26 | 90 TABLET in 1 BOTTLE, DISPENSING (51655-106-26) | Glipizide | Northwind Health Company, LLC | 2014-12-30 |
| 51655-0106-52 | 30 TABLET in 1 BOTTLE, DISPENSING (51655-106-52) | Glipizide | Northwind Health Company, LLC | 2014-12-30 |
| 51655-0810-25 | 60 TABLET in 1 BOTTLE (51655-810-25) | Glipizide | Northwind Health Company, LLC | 2015-09-30 |
| 51655-0810-26 | 90 TABLET in 1 BOTTLE (51655-810-26) | Glipizide | Northwind Health Company, LLC | 2015-09-30 |
| 51655-0810-52 | 30 TABLET in 1 BOTTLE (51655-810-52) | Glipizide | Northwind Health Company, LLC | 2015-09-30 |
| 60505-0141-00 | 100 TABLET in 1 BOTTLE (60505-0141-0) | Glipizide | Apotex Corp. | 2002-09-25 |
| 60505-0141-01 | 1000 TABLET in 1 BOTTLE (60505-0141-1) | Glipizide | Apotex Corp. | 2002-09-25 |
| 60505-0141-02 | 500 TABLET in 1 BOTTLE (60505-0141-2) | Glipizide | Apotex Corp. | 2002-09-25 |
| 60505-0141-08 | 18000 TABLET in 1 BOTTLE (60505-0141-8) | Glipizide | Apotex Corp. | 2002-09-25 |
| 60505-0142-00 | 100 TABLET in 1 BOTTLE (60505-0142-0) | Glipizide | Apotex Corp. | 2002-09-25 |
| 60505-0142-01 | 1000 TABLET in 1 BOTTLE (60505-0142-1) | Glipizide | Apotex Corp. | 2002-09-25 |
Observed labelers:
Bryant Ranch Prepack (23) ·
A-S Medication Solutions (19) ·
Proficient Rx LP (19) ·
Aphena Pharma Solutions - Tennessee, LLC (18) ·
Advagen Pharma Limited (15) ·
Preferred Pharmaceuticals Inc. (15)
· +18 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.